Technical guide

Choosing liposomal ingredients: from dossier to supply

Selecting a liposomal ingredient involves more than a product name or a price per kilogram. The intended serving, manufacturing method, documentation and supply plan need to be assessed together. A clear project brief provides a more direct route to a relevant sample and a quotation that can be compared on a consistent basis.

Define the intended product first

Capsules, sachets and liquid products may have different requirements for the same active. Formulation teams should share the intended active amount and format, while procurement provides batch size, annual demand and delivery plans.

At Biontera, we consider ingredient supply alongside formulation consultancy and technical dossier review. The aim is to clarify how the proposed material fits the intended product from the outset.

  • Target market, intended use and finished-product format.
  • Active amount per serving and other ingredients.
  • Planned production volume, initial batch and estimated annual requirement.
  • Manufacturing conditions, packaging and target delivery date.

Review two complementary files

A batch CoA reports stated analytical results for a particular batch. The general product dossier covers broader information such as composition, specification, characterisation and available research. Product codes and manufacturer details should connect the two.

Dossier topicInformation to review
Identity and compositionActive, carrier components, product code and manufacturer
Specification and CoAMethods, units, limits and batch results
Liposomal characterisationMethod, sample identity and report date
ResearchTested formulation, dose and type of outcome
Manufacturing and storageConditions of use, packaging and stability information
Supply documentationOrigin, traceability and project-relevant supporting documents

Source: FDA (2018) — Liposome Drug Products; technical reference for composition and characterisation; NCI — Characterisation methods and product-specific assessment

Add a serving calculation to the kilogram price

A cost assessment should consider nominal active content, intended serving and manufacturing usability together. Materials with different active percentages can then be compared using the same calculation basis.

A simple starting calculation divides the intended active amount by the active fraction to obtain the nominal ingredient requirement per serving. For illustration only, a material containing 20% active would require 500 mg to provide a nominal 100 mg of active. This is neither a recommended use level for a particular product nor a bioequivalence proposal.

Keep a decision record between sample and purchase

Record the product code and batch identity of the sample. Keep appearance, process-compatibility and analytical observations from formulation work in the same file. Clarifying the code, technical scope, packaging, lead time and documentation before ordering makes subsequent steps easier.

If research findings will be used in commercial communications, their relevance to the offered material and conditions in the target market require separate assessment. Reviewing a technical dossier does not guarantee a particular regulatory outcome.

What to send Biontera

Share a short project brief, requested actives, intended format and estimated annual demand. We can use this information to assess ingredient options, available documentation and the sample plan. Formulation development and application-dossier preparation needs can be considered within the same project.

Common questions

Do I need a finished formula for an initial discussion?

No. Target actives, format, serving amount and an approximate production plan can provide a starting point.

Is a CoA enough to select an ingredient?

A CoA is an important batch document. Suitability also requires review of composition, specification, characterisation and processing information.

Does a research dossier guarantee application approval?

No. Research contributes to technical assessment. The application is evaluated for the particular product and applicable conditions; the outcome rests with the competent authority.

Explore the portfolio

From understanding to selection.

Let’s assess your next formulation.

Share your dosage form, intended amount per serving and estimated annual requirement. We can plan ingredient selection, technical documentation and sample evaluation together.

Discuss documents and samples